Hybrid polypeptides with selectable properties

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel...

Full description

Saved in:
Bibliographic Details
Main Authors SOARES CHRISTOPHER J, LEWIS DIANA Y, GHOSH SOUMITRA S, JODKA CAROLYN M, D'SOUZA LAWRENCE J, PARKES DAVID G, LEVY ODILE E, HANLEY MICHAEL R, MACK CHRISTINE M
Format Patent
LanguageEnglish
Published 04.05.2006
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.
Bibliography:Application Number: US20050055093